Skip to main content

Question for Department of Health and Social Care

UIN 1507, tabled on 13 May 2022

To ask the Secretary of State for Health and Social Care, what plans his Department has to make Evusheld available to immunocompromised people.

This answer is the replacement for a previous holding answer.

Answered on

7 June 2022

Evusheld has been granted conditional marketing approval by the Medicines and Healthcare products Regulatory Agency (MHRA) on 17 March 2022. However, the MHRA highlighted uncertainty over the appropriate dose needed for protection against the Omicron variant. Understanding the efficacy of Evusheld is necessary prior to any procurement or deployment.

The UK Health Security Agency is currently undertaking further testing on the treatment’s effectiveness against the Omicron variant. This will inform any decisions on the potential procurement of this treatment.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.